Synopsys/$SNPS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Synopsys

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Ticker

$SNPS
Primary listing

Industry

Software

Employees

20,000

ISIN

US8716071076

Synopsys Metrics

BasicAdvanced
$78B
36.28
$13.85
1.11
-

What the Analysts think about Synopsys

Analyst ratings (Buy, Hold, Sell) for Synopsys stock.

Bulls say / Bears say

Synopsys forecasts third-quarter revenue between $1.76 billion and $1.79 billion, surpassing Wall Street's average estimate of $1.76 billion, driven by strong demand for its semiconductor design software amid increased AI chip development investments. (reuters.com)
The U.S. Federal Trade Commission approved Synopsys's $35 billion merger with Ansys, conditional on asset divestitures, signaling regulatory progress and potential for enhanced product offerings. (reuters.com)
Synopsys's collaboration with Nvidia on generative AI and digital twins is central to the future design, automation, and manufacturing of chips, positioning the company at the forefront of AI-driven semiconductor innovation. (markets.businessinsider.com)
Synopsys has suspended all sales and services in China due to newly imposed U.S. export restrictions, potentially impacting 16% of its business and affecting China's chipmaking capabilities. (reuters.com)
The company withdrew its financial guidance for the third quarter and full fiscal year 2025, citing uncertainties created by new U.S. export restrictions targeting China, leading to a 2.5% drop in share value. (reuters.com)
Synopsys's stock fell 7% after its fiscal first-quarter guidance came in lower than analysts had anticipated, with projected earnings per share of $2.77 to $2.82, well below the $3.53 expected. (nasdaq.com)
Data summarised monthly by Lightyear AI. Last updated on 26 Jun 2025.

Synopsys Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Synopsys Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SNPS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs